Overview

Intraluminal Peppermint Oil and Adenoma Detection Rate in Screening Colonoscopy

Status:
Completed
Trial end date:
2022-06-30
Target enrollment:
0
Participant gender:
All
Summary
This is a prospective randomized placebo-controlled trial to evaluate the efficacy of peppermint oil spraying into the colonic lumen through the scope channel during screening colonoscopy. The primary outcome is to compare the colonic peristalsis between peppermint oil and placebo. The secondary outcomes compare the procedural time, polyp detection rate, adenoma detection rate, and adverse events.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Mahidol University
Collaborator:
The Royal College of Physicians of Thailand
Treatments:
Peppermint oil
Criteria
Inclusion Criteria:

- Participants with age > 18 years who attended for colorectal cancer screening
colonoscopy.

Exclusion Criteria:

- Participants who had been colectomy

- Participants who diagnosed of inflammatory bowel disease or polyposis syndrome.

- Participants who had been took anti-spasmosic drugs prior to colonoscopy within 24
hours (Anticholibergic/Antimuscarinic : Hyoscine(Buscopan®), Dicyclomine(Berclomine®)
or Smooth muscle relaxant : Mebeverine(Duspatin®,Colofac®), Pinaverium
bromide(Dicetel®), Alverine(Meteospasmyl®), Peppermint oil(Colpermin®))

- Participants with Prothrombin time > 3 second ULN, INR > 1.5 or Platelet < 50,000.

- Pregnancy or breast feeding

- Participants who cannot consent.

- Participants who had history of peppermint oil allergy.